Do longevity supplements actually work? What the human evidence shows

The longevity shelf has never been fuller. NMN and NAD boosters, resveratrol, taurine, urolithin A, spermidine, and the prescription drugs rapamycin and metformin used off-label, all sold on the promise of slowing aging. Underneath the marketing sits one stubborn fact that the industry rarely leads with: not a single supplement has been shown, in a human trial, to make people live longer. The strongest evidence is either in mice or on surrogate markers that stand in for aging rather than measuring it.

The bar almost nothing clears

Proving a supplement extends human lifespan would take a trial that follows thousands of people for years or decades and measures how long they live. No such trial has been completed for any longevity supplement. So when a product claims to slow aging, the right question is always: slow it measured how? Usually the answer is a blood marker, a cell-level readout or a result in animals, not years of life.

Rapamycin and resveratrol: the mouse gap

Rapamycin has the most impressive lifespan data of anything in this field. In the rigorous federally funded mouse programme it extended median lifespan by double digits. But those are mice. The main human trial, in 115 adults over 48 weeks, was essentially a safety study and showed small, sex-specific effects, not life extension. Resveratrol is the cautionary tale on the other side. It was the molecule that launched the modern longevity-supplement boom, then failed to extend life in the same mouse programme, and stumbled badly as a pharmaceutical when a developer halted a version over kidney-toxicity concerns.

Taurine: a headline, then a correction

Taurine shows how fast a longevity story can wobble. A 2023 paper in a major journal reported that taurine extended lifespan in mice and that blood taurine falls with age in several species, and it made headlines worldwide. In 2025 a study led by researchers at the National Institute on Aging found that circulating taurine does not reliably decline with age after all, undercutting the core human rationale. The human part of the original work was observational, not a trial. Scientists are not dismissing it, but they are treating it as an open question rather than a reason to supplement.

NMN, urolithin A and omega-3: real effects, wrong target

Some longevity supplements do measurable things, just not the thing on the label. NMN and NAD boosters reliably raise NAD levels in the blood, but the downstream health benefits in people are weak or absent, and the FDA only reinstated NMN as a legal supplement ingredient in September 2025 after a period of limbo. Urolithin A, sold as Mitopure, improved muscle strength in a human trial, but it missed the trial's pre-set main goal, and stronger muscles are not the same as a longer life. Omega-3, vitamin D and exercise together nudged biological-aging clocks by a few months in one trial, a biomarker result that a statistician reviewing it was careful to keep in proportion.

Our take

The longevity-supplement market runs on a sleight of hand: impressive results in mice or on surrogate markers, presented as if they were proof of a longer human life. Rapamycin's mouse data is genuinely interesting, taurine is an open question, and a few supplements move a blood marker or a muscle test. None of that is evidence you will live longer for taking them, and supplements are not tested for safety or effectiveness before they reach the shelf. The moves with actual longevity evidence are the dull ones: exercise, sleep, not smoking, a decent diet, and the screenings your doctor recommends. Do those first. If you still want to try a supplement, treat it as a personal experiment on a surrogate marker, keep your doctor in the loop, and hold your expectations where the evidence is.

This is general information, not medical advice. Some of these substances interact with medication or carry real risks, so talk to a clinician before starting any of them.